Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Navidea Biopharmaceuticals (DE:NO1A)
MUNICH:NO1A
Navidea (NO1A) Stock Price & Analysis
0 Followers
NO1A Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.03 - €0.25
Previous Close€0.05
Volume0.00
Average Volume (3M)N/A
Market Cap
€4.42M
Enterprise Value€1.14M
Total Cash (Recent Filing)$3.86M
Total Debt (Recent Filing)$10.70K
Price to Earnings (P/E)N/A
Beta0.23
Next Earnings
May 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding99,830,635
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.24
R-Squared0.01
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)-1.86
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.30
P/FCF Ratio0.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-22.74
Enterprise Value/Gross Profit17.85
Enterprise Value/Ebitda-0.20
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
NO1A FAQ
What was Navidea Biopharmaceuticals’s price range in the past 12 months?
Navidea Biopharmaceuticals lowest stock price was €0.03 and its highest was €0.25 in the past 12 months.
What is Navidea Biopharmaceuticals’s market cap?
Currently, no data Available
When is Navidea Biopharmaceuticals’s upcoming earnings report date?
Navidea Biopharmaceuticals’s upcoming earnings report date is May 07, 2024 which is in 5 days.
How were Navidea Biopharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Navidea Biopharmaceuticals overvalued?
According to Wall Street analysts Navidea Biopharmaceuticals’s price is currently Overvalued.
Does Navidea Biopharmaceuticals pay dividends?
Navidea Biopharmaceuticals does not currently pay dividends.
What is Navidea Biopharmaceuticals’s EPS estimate?
Navidea Biopharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Navidea Biopharmaceuticals have?
Currently, no data Available
What happened to Navidea Biopharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Navidea Biopharmaceuticals?
Currently, no hedge funds are holding shares in DE:NO1A
---
Navidea Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
---
NO1A Earnings Call
Q4 2023
0:00 / 0:00
---
Technical Analysis
---